Cargando…

Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome

Detalles Bibliográficos
Autores principales: González Pérez, Alejandra, Carbonell Martínez, Antonio, Escudero Pastor, Ana Isabel, Navarro Garrido, Cristina, Miralles López, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278159/
https://www.ncbi.nlm.nih.gov/pubmed/32523680
http://dx.doi.org/10.1186/s13601-020-00325-y
_version_ 1783543277189857280
author González Pérez, Alejandra
Carbonell Martínez, Antonio
Escudero Pastor, Ana Isabel
Navarro Garrido, Cristina
Miralles López, Juan Carlos
author_facet González Pérez, Alejandra
Carbonell Martínez, Antonio
Escudero Pastor, Ana Isabel
Navarro Garrido, Cristina
Miralles López, Juan Carlos
author_sort González Pérez, Alejandra
collection PubMed
description
format Online
Article
Text
id pubmed-7278159
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72781592020-06-09 Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome González Pérez, Alejandra Carbonell Martínez, Antonio Escudero Pastor, Ana Isabel Navarro Garrido, Cristina Miralles López, Juan Carlos Clin Transl Allergy Research Letter BioMed Central 2020-06-08 /pmc/articles/PMC7278159/ /pubmed/32523680 http://dx.doi.org/10.1186/s13601-020-00325-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
González Pérez, Alejandra
Carbonell Martínez, Antonio
Escudero Pastor, Ana Isabel
Navarro Garrido, Cristina
Miralles López, Juan Carlos
Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title_full Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title_fullStr Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title_full_unstemmed Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title_short Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome
title_sort pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with ltp syndrome
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278159/
https://www.ncbi.nlm.nih.gov/pubmed/32523680
http://dx.doi.org/10.1186/s13601-020-00325-y
work_keys_str_mv AT gonzalezperezalejandra prup3oralimmunotherapyefficacyinducedimmunologicalchangesandqualityoflifeimprovementinpatientswithltpsyndrome
AT carbonellmartinezantonio prup3oralimmunotherapyefficacyinducedimmunologicalchangesandqualityoflifeimprovementinpatientswithltpsyndrome
AT escuderopastoranaisabel prup3oralimmunotherapyefficacyinducedimmunologicalchangesandqualityoflifeimprovementinpatientswithltpsyndrome
AT navarrogarridocristina prup3oralimmunotherapyefficacyinducedimmunologicalchangesandqualityoflifeimprovementinpatientswithltpsyndrome
AT miralleslopezjuancarlos prup3oralimmunotherapyefficacyinducedimmunologicalchangesandqualityoflifeimprovementinpatientswithltpsyndrome